Corteva Inc

Análisis de la acción Corteva Inc (CTVA)

$12.880

0.000 (0.00%)Al cierre

Loading chart…
Máximo
13.170
Apertura
12.988
Precio medio ponderado por volumen
12.91
Volumen
15.71M
Capitalización
37.39B
Mínimo
12.690
Importe
202.90M
EV/EBITDA, TTM
4.81

Corteva, Inc. is a global pure-play agriculture company that combines customer engagement and operational execution to deliver solutions. The Company generates advantaged market preference through its distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. It serves the global agricultural input industry with crop protection solutions that improve farmer productivity and profitability by protecting against weeds, insects and other pests, and disease, and by supporting overall crop health both above and below ground via nitrogen management and seed applied technologies. The Company's offerings includes herbicides, insecticides, nitrogen stabilizers, pasture and range management herbicides and biologicals and other nature-based products.

www.corteva.com

Análisis de IA of Corteva Inc (CTVA)

Vender

Corteva is not a good buy right now due to a current price of $12.88, which is significantly below analyst targets, and a concerning RSI of 7.338 indicating oversold conditions. The stock has also experienced a drastic 80.99% decline year-to-date, suggesting a lack of investor confidence and potential ongoing volatility.

Métricas de valoración

El PER previsto actual de Corteva Inc (CTVA) es 19.08, frente a su media de 5 años de 20.35.

PER previsto

Valor razonable
Media 5A P/E
20.35
P/E actual
19.08
Sobrevalorada
22.41
Infravalorada
18.28

EV/EBITDA previsto

Muy infravalorado
Media 5A EV/EBITDA
12.03
EV/EBITDA actual
4.81
Sobrevalorada
14.36
Infravalorada
9.71

Precio/ventas previsto

Muy infravalorado
Media 5A P/S
2.37
P/S actual
1.03
Sobrevalorada
2.71
Infravalorada
2.04

Escenarios de precio de Alphio AI para CTVA

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%CTVA

$82.20

Precio del escenario

B

Base

Base · 50%CTVA

$67.79

Precio del escenario

B

Bajista

Bajista · 25%CTVA

$54.24

Precio del escenario

Ballenas con CTVA en cartera

S

Staley Capital Advisers, Inc.

+ Con en carteraCTVA

+2.00%

Rentabilidad a 3 meses

C

Clifford Swan Investment Counsel LLC

+ Con en carteraCTVA

+1.37%

Rentabilidad a 3 meses

D

Dearborn Partners L.L.C.

+ Con en carteraCTVA

+0.32%

Rentabilidad a 3 meses

Z

ZWJ Investment Counsel Inc

+ Con en carteraCTVA

+0.03%

Rentabilidad a 3 meses

A

Aristotle Capital Management, LLC

+ Con en carteraCTVA

-1.51%

Rentabilidad a 3 meses

R

Rokos Capital Management LLP

+ Con en carteraCTVA

-2.00%

Rentabilidad a 3 meses

Cronología de eventos

2026-10-15 (ET)

10:30:00

RBC Cuts FMC Q3 EBITDA Guidance to $538M

2026-10-06 (ET)

16:30:00

McKesson and CD&R Agree to Acquire Option Care Health for $32.05 per Share

12:00:00

Major Averages Rise for Second Day Amid Treasury Yield Retreat

10:00:00

Constellation Energy Gains $41.50 to $309.12

09:00:00

Stock Futures Rise as Oil Prices Ease

Noticias

Preguntas frecuentes sobre CTVA, respondidas por Alphio AI

Corteva, Inc. is a global pure-play agriculture company that combines customer engagement and operational execution to deliver solutions. The Company generates advantaged market preference through its distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. It serves the global agricultural input industry with crop protection solutions that improve farmer productivity and profitability by protecting against weeds, insects and other pests, and disease, and by supporting overall crop health both above and below ground via nitrogen management and seed applied technologies. The Company's offerings includes herbicides, insecticides, nitrogen stabilizers, pasture and range management herbicides and biologicals and other nature-based products. It operates in the Basic Materials sector.

Corteva is not a good buy right now due to a current price of $12.88, which is significantly below analyst targets, and a concerning RSI of 7.338 indicating oversold conditions. The stock has also experienced a drastic 80.99% decline year-to-date, suggesting a lack of investor confidence and potential ongoing volatility.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar